Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us M. Djordjevic
University Medical Center Groningen

M. Djordjevic

M.D., Ph.D. Candidate
No picture available
E-mail:
m.djordjevic umcg.nl

Research interests

My research is centered around psychosocial factors in the early stages of psychotic disorders.

Publications

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial

Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT study

Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment study

Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study

Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis

Addressing the Evidence to Practice Gap: What to Expect from International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium

Antipsychotica na een eerste psychose

Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients

Sustainable Development Goals

SDG 3 - Good Health and Well-beingSDG 16 - Peace, Justice and Strong Institutions

More information about the Sustainable Development Goals.